| BIO Links |
BIO LinksBIO Issues and Resources
The Biotechnology Innovation Organization (BIO) advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research whether it be developing next-generation drugs, the next major advancement in agriculture or fuel to move the world. Check out these resources to understand the most pressing issues and educate colleagues, employees and community stakeholders.
ADVOCATE. CHANGE. INNOVATE MORE.![]() Human HealthTo ensure transformative therapies get to the people who need them, BIO is committed to advancing policies that foster innovation, fuel investment and encourage the entrepreneurial spirit that has made America the global leader in this cutting-edge field. Learn More
Intellectual PropertyIntellectual property is the lifeblood of the biotechnology industry. Strong patents, and an efficient, predictable, and objective patent system, are critical to ensuring a steady stream of capital to biotechnology companies. Learn More![]() Patient AdvocacyThe commitment to discovering and developing innovative medicines to fight and cure disease and improve the lives of patients. Learn More![]() Agriculture & EnvironmentEmbracing the key role biotechnology plays in protecting our planet’s resources, driving a strong economy and improving people’s lives. Learn More![]() InternationalGlobal collaboration is increasingly important as governments around the world seek to develop comprehensive policy frameworks to support biotechnology innovation. Learn MoreReady to Join?Delaware Bio members are part of a dynamic, collaborative community of life science companies and service providers, researchers and entrepreneurs of every size from across the state. Members benefit from exclusive cost saving programs, networking opportunities and business resources. Join Now
Stay Up To Date
Sign up to receive our newsletter, upcoming event notifications, and industry news
Sign Up Now
Our Sponsors |
10/27/2025Team led by NIIMBL is Selected for Gates Grand Challenge $10.5 Million Funding Award
10/23/2025Viewpoint: Innovation and access is the life science industry’s central mission
10/23/2025Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
10/20/2025LabWare expands global lab software solutions from Delaware headquarters
12/10/2025
2025 December BioBriefing
1/22/2026
January 2026 BioBreakfast